Athira Pharma Announces Initiation of Open Label Extension Study for LIFT-AD and ACT-AD …,

(NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop …, (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop …, Read More

Scroll to Top